Bioverativ Appoints Tim Harris Executive Vice President, Research and Development
Go back to Bioverativ Appoints Tim Harris Executive Vice President, Research and Development| (NASDAQ: BIVV) | Delayed: 104.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.98 | 52 Week High | $ | |||
| Open | $0.60 | 52 Week Low | $ | |||
| Day High | $104.98 | P/E | N/A | |||
| Day Low | $104.98 | EPS | $ | |||
| Volume | 472 | |||||
| (NASDAQ: OPGN) | Delayed: 1.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $4.65 | |||
| Open | $1.96 | 52 Week Low | $0.87 | |||
| Day High | $1.96 | P/E | N/A | |||
| Day Low | $1.96 | EPS | $0.00 | |||
| Volume | 266,473 | |||||
